Biomineralize Mitochondria in Metal‐Organic Frameworks to Promote Mitochondria Transplantation From Non‐Tumorigenic Cells Into Cancer Cells
Smart Medicine · 2025-03 · 4 (1)
DOI: 10.1002/smmd.134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Smart Medicine, online erschienen am 26.02.2025. Verfasst von Jun-Nian Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mitochondria are crucial to cellular physiology, and growing evidence highlights the significant impact of mitochondrial dysfunction in diabetes, aging, neurodegenerative disorders, and cancers. Therefore, mitochondrial transplantation shows great potential for therapeutic use in treating these diseases. However, transplantation process is notably challenging due to very low efficiency and rapid loss of bioactivity post‐isolation, leading to poor reproducibility and reliability. In this study, we develop a novel strategy to form a nanometer‐thick protective shell around isolated mitochondria using Metal‐Organic Frameworks (MOFs) through biomineralization. Our findings demonstrate that this encapsulation method effectively maintains mitochondria bioactivity for at least 4 weeks at room temperature. Furthermore, the efficiency of intracellular delivery of mitochondria is significantly enhanced through the surface functionalization of MOFs with polyethyleneimine (PEI) and the cell‐penetrating peptide Tat. The successful delivery of mitochondria isolated from non‐tumorigenic cells into cancer cells results in notable tumor‐suppressive effects. Taken together, our technology represents a significant advancement in mitochondria research, particularly on understanding their role in cancer. It also lays the groundwork for utilizing mitochondria as therapeutic agents in cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland.
- Turku Bioscience Centre University of Turku and Åbo Akademi University Turku Finland.
- Beijing Institute of Radiation Medicine Beijing China.
- Department of Endocrinology Key Laboratory of National Health & Family Planning Commission for Male Reproductive Health National Research Institute for Family Planning Beijing China.
- Chemistry and Advanced Materials Faculty of Engineering and Natural Sciences Tampere University Tampere Finland.
- Department of Radiation Oncology Stanford University School of Medicine Stanford California USA.
ORCID-Profile: Jun-Nian Zhou
Zitieren
APA
Zhou, J. N., Liu, C., Wang, Y., Guo, Y., Xu, X. Y., Vuorimaa-Laukkanen, E., Koivisto, O., Filppula, A. M., Ye, J., & Zhang, H. (2025). Biomineralize Mitochondria in Metal‐Organic Frameworks to Promote Mitochondria Transplantation From Non‐Tumorigenic Cells Into Cancer Cells. Smart Medicine, 4(1). https://doi.org/10.1002/smmd.134
Vancouver
Zhou JN, Liu C, Wang Y, Guo Y, Xu XY, Vuorimaa-Laukkanen E, et al. Biomineralize Mitochondria in Metal‐Organic Frameworks to Promote Mitochondria Transplantation From Non‐Tumorigenic Cells Into Cancer Cells. Smart Medicine. 2025;4(1). doi:10.1002/smmd.134
BibTeX
@article{Zhou2025,
author = {Zhou, Jun-Nian and Liu, Chang and Wang, Yonghui and Guo, Yong and Xu, Xiao-Yu and Vuorimaa-Laukkanen, Elina and Koivisto, Oliver and Filppula, Anne M and Ye, Jiangbin and Zhang, Hongbo},
title = {Biomineralize Mitochondria in Metal‐Organic Frameworks to Promote Mitochondria Transplantation From Non‐Tumorigenic Cells Into Cancer Cells},
journal = {Smart Medicine},
year = {2025},
volume = {4},
number = {1},
doi = {10.1002/smmd.134}
}
EUVIMED